301 related articles for article (PubMed ID: 36946374)
1. Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients.
Liu XR; Qi YY; Zhao YF; Cui Y; Zhao ZZ
Ren Fail; 2023 Dec; 45(1):2174355. PubMed ID: 36946374
[TBL] [Abstract][Full Text] [Related]
2. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
3. Value of sTNF-R1 and linc0597 as indicators for disease activity and diagnosis of lupus nephritis.
Zheng CZ; Yan WW; Luo YL; Wang TL; Shu YB
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5582-5591. PubMed ID: 32495893
[TBL] [Abstract][Full Text] [Related]
4. Serum uric acid as a sensitive concordant marker with lupus nephritis and new onset of renal damage: a prospective cohort study.
Elnady B; Almalki A; Abdel-Fattah MM; Desouky DE; Attar M
Clin Rheumatol; 2021 May; 40(5):1827-1834. PubMed ID: 33094396
[TBL] [Abstract][Full Text] [Related]
5. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
Front Immunol; 2022; 13():885307. PubMed ID: 35720325
[TBL] [Abstract][Full Text] [Related]
6. The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus.
Spinelli FR; Garufi C; Truglia S; Pacucci VA; Morello F; Miranda F; Perricone C; Ceccarelli F; Valesini G; Conti F
Clin Exp Rheumatol; 2019; 37(6):899-905. PubMed ID: 31074728
[TBL] [Abstract][Full Text] [Related]
7. Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis.
Häyry A; Faustini F; Zickert A; Larsson A; Niewold TB; Svenungsson E; Oke V; Gunnarsson I
Lupus Sci Med; 2022 Sep; 9(1):. PubMed ID: 36104119
[TBL] [Abstract][Full Text] [Related]
8. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
[TBL] [Abstract][Full Text] [Related]
9. Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients.
Martin M; Trattner R; Nilsson SC; Björk A; Zickert A; Blom AM; Gunnarsson I
Front Immunol; 2020; 11():582737. PubMed ID: 33133102
[TBL] [Abstract][Full Text] [Related]
10. Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis.
Soliman SA; Stanley S; Vanarsa K; Ismail F; Mok CC; Mohan C
Front Immunol; 2022; 13():910993. PubMed ID: 36091001
[TBL] [Abstract][Full Text] [Related]
11. Human Epididymis Protein 4: A Novel Biomarker for Lupus Nephritis and Chronic Kidney Disease in Systemic Lupus Erythematosus.
Yang Z; Zhang Z; Qin B; Wu P; Zhong R; Zhou L; Liang Y
J Clin Lab Anal; 2016 Nov; 30(6):897-904. PubMed ID: 27075413
[TBL] [Abstract][Full Text] [Related]
12. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
[TBL] [Abstract][Full Text] [Related]
13. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
[TBL] [Abstract][Full Text] [Related]
14. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors of childhood systemic lupus erythematosus with thyroid dysfunction].
Zhang YY; Huang LM; Cao L; Zhi YZ; Zhang JJ
Zhonghua Er Ke Za Zhi; 2023 Mar; 61(3):250-255. PubMed ID: 36849353
[No Abstract] [Full Text] [Related]
16. Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.
Amer AS; Abdel Moneam SM; Hashaad NI; Yousef EM; Abd El-Hassib DM
Clin Rheumatol; 2024 Mar; 43(3):1015-1021. PubMed ID: 38294724
[TBL] [Abstract][Full Text] [Related]
17. ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus.
Parodis I; Gokaraju S; Zickert A; Vanarsa K; Zhang T; Habazi D; Botto J; Serdoura Alves C; Giannopoulos P; Larsson A; Svenungsson E; Gunnarsson I; Mohan C
Rheumatology (Oxford); 2020 Sep; 59(9):2237-2249. PubMed ID: 31722419
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-2 as a biomarker for lupus nephritis.
Luong PT; Nguyen TTD; Nguyen NT; Ngo HT; Nguyen HN; Pho DH; Nguyen HT
Pediatr Int; 2023; 65(1):e15613. PubMed ID: 37698235
[TBL] [Abstract][Full Text] [Related]
19. Association of Systemic Lupus Erythematosus Disease Activity With Choroidal Thickness.
Lee I; Gomez AR; Kim AHJ; Coble DW; Marshall B; Shah A; Eisen S; Apte RS; Li T
J Clin Rheumatol; 2024 Mar; 30(2):e58-e62. PubMed ID: 37798827
[TBL] [Abstract][Full Text] [Related]
20. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
